Safe Fertility Group PCL (BKK:SAFE)

Market Cap	1.70B -36.7%
Revenue (ttm)	700.21M -7.2%
Net Income	132.95M +0.4%
EPS	0.43 -2.0%
Shares Out	303.95M
PE Ratio	12.98
Forward PE	11.28
Dividend	0.41 (7.32%)
Ex-Dividend Date	May 7, 2026

Volume	119,600
Open	5.60
Previous Close	5.60
Day's Range	5.55 - 5.70
52-Week Range	5.55 - 7.95
Beta	0.24
Analysts	Buy
Price Target	8.48 (+53.21%)
Earnings Date	Aug 7, 2026

About Safe Fertility Group PCL

Safe Fertility Group Public Company Limited, together with its subsidiaries, provides fertility medical center services in Thailand. It operates through two segments, Obstetrics and Gynecology hospital and medical laboratory, and Cosmetic Dermatology. The company offers in vitro fertilization, intrauterine insemination, egg freezing, and embryo transfer for women; and sperm freezing and analysis, magnetic activated cell sorting, IMSI, THESIS, and PESA services for men. It also provides couple checkup, embryoscope plus, preimplantation genetic t...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2007
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: SAFE

Financial Performance

In 2025, Safe Fertility Group PCL's revenue was 701.92 million, a decrease of -15.44% compared to the previous year's 830.13 million. Earnings were 131.10 million, a decrease of -21.54%.

Analyst Summary

According to 3 analysts, the average rating for SAFE stock is "Buy." The 12-month stock price target is ฿8.48, which is an increase of 53.21% from the latest price.

Price Target

฿8.48

(53.21% upside)

Analyst Consensus: Buy